The patients were in the chronic phase and presented motor alterations with akinetic-rigid characteristics. In the striatum, a 45% reduction in DAT binding and a 73% reduction in D2R were observed compared to control patients.No data are presented regarding the mood or anxiety in the patients. The gene discussed is SLC6A3; the disease is Anxiety.